Member Info for risehall1

Much of the rest of Europe has outperformed the UK on vaccine rollout, having a higher proportion of the population vaccinated. Even countries like Portugal outperform the UK. They are also not dithering about vaccinating young people nor dithering over booster jabs. In places like France they have also been more willing to require people to have vaccines and have kept in place measures such as mask wearing. Meanwhile in the highly urbanised and overcrowded UK it is easy come easy go with a lack of decisive leadership and the desire to promote the interests of a small wealthy elite of individuals and businesses over the health and wellbeing of the wider population. Of course, with our world leading health system what could possibly go wrong? The only thing this government has got right has been the early vaccine roll out.

Things are gonna get real messy for these shorters when they get squeezed. Think of like someone with a load of excrement in their hands clapping as hard as they can. Serve em right.

Unless you are a US company it is difficult to do business there. They are more protective of their national interest and prefer US products from US owned companies. That is even moreso in the case of products that require FDA approval as they impose very strict requirements and there are lengthy waits for approval. Setting up a US subsidiary and office was a big step forward. A Nasdaq listing might be a good idea as well, as would a US manufacturing presence, even if it is subcontracted.

If only he would ramp the company!! He's just not the type. He comes across as a bit of an introvert and a scientist. I suspect he is very good at the technical stuff but at no point have I ever thought of Novacyt as a company who shout about themselves. Though I bet he can dance better than Michael Gove. Sophisticated communications and ramping and Novacyt just do not fit together in the same sentence.

What was wrong with the original exsig kits?

I don't think it is because if it was I would not have expected a further contract with the DHSC for more Promate. The fact that Novacyt's point of care test had been validated and approved by DHSC before the order and the subsequent order for more Promate all makes it a little puzzling. It suggests the equipment is of satisfactory quality and works as intended?

Volume is actually quite high now. Markets as a whole are very volatile as well.

See this https://www.bloomberg.com/news/articles/2021-10-03/biontech-ceo-says-new-covid-vaccines-will-be-needed-in-2022-ft. If they are correct that covid will escape current vaccines demand for pcr testing may persist for longer than many envisage.

I see what you mean. Were you the one who previously called the top at £12.50. Personally I have always been a bit sceptical of charting but some seem to do it well. But fundamentals - the fundamentals still have to be there. Now I thought testing was on the wane but for some reason diagnostic stocks are in demand today.

Your messages are too long. No one can read them, their batteries went dead after your first message.

But on what basis have you chosen a target of £19.15? It is odd that diagnostic stocks across the board are up today. I hope there is not going to be some left of field bad news on vaccine escape - that might be a driver for the diagnostics sector.

The big diagnostic companies are awash with cash and will definitely be looking at acquisitions. Where you see the DHSC dispute as a barrier to a takeover, a predator might well see it as an opportunity to acquire a rival at a low price in a position of weakness. If you net out cash at bank and the order book over the next 12 months, there might well be a bargain to be had.

If there is ever a major war or serious upheavel the first thing to go down will be electronic communications and the internet. In fact, the Russians opening gambit in the event of a nuclear war was to be a bomb dropped in the North Sea intended to knock out communications and overload the national grid. That can't ever happen you say? We had two world wars in the last century. We're in the middle of a pandemic. These things happen. Your gold coins and bullion won't disappear but your bitcoin will. Gold has been a store of wealth for thousands of years, it is a physical commodity and it is rare. It will survive as a store of wealth.

If they want some more votes they can pony up their own hard earned cash and buy some more shares themselves.

That is a good question for Mandy. Obviously they weren't expecting not to have a quorum and thought they could drop an RNS about delays to LFT until after the AGM! Talk about treating shareholders like muppets...

Actually there may be much more than £77 million in cash depending on the outcome of the DHSC and continued demand for testing. Incidentally, demand for PCR is more likely to outlast LFT because PCR can distinguish vatiants and other illnesses. With no debt, all they need to do is make sure they can turn some sort of a profit beyond 2021 if demand for covid testing wanes. That shouldn't be too difficult with their expertise and cash pile, plus they now have a vast sales network and contacts. Novacyt no longer just develop tests, they also have a surveillance capability and the ability to manufacture reagants and machines (from the acquisition of IT IS). I still think they are missing a trick not seeing pandemics themselves as a future market because governments will be spending tens of billions in the coming decades on surveillance, consulting/advice on pandemic strategy and maintaining diagnostic capability. Look at how agriculture and defence prospered after WW2. So don't be too pessimistic. It is also worth looking at how other diagnostic companies like Quigen have grown over the years turning from a tiny business with a handful of staff into a multibillion company employing thousands.

Yes, but if as a result of improved treatments covid becomes a more easily treated and less serious disease there will be no need for mass testing. At some point demand for testing will wane. Future demand for testing may be hard to predict. On one hand vaccines are being rolled out and new treatments developed, but on the other had the virus could mutate to escape the current vaccines and there are many people who are not vaccinated. Novacyt have the safety pillow of a big cash reserve but need to be expanding their product range for the future.

Of those who did vote though, how many voted yes?

Shareholders revolt and the French markets like it! Viva la revolution! Bring forth the management and roll out the guilotine. Can we draw lucky straws as to who gets to catch the heads in the wicker basket?

I don't think they can, he has to be voted in. Personally I think this French quorum thing is bloody fantastic for holding management to account. Couldn't care less if it causes the SP to drop a little while it is sorted. If it applies the thumbscrews to management thats fine by me.